PortViewPortView
DexCom logo

DexCom (DXCM) Stock Analysis

NASDAQHealth CareMedical Devices

$90.87+0.81%
1-year price historyRange $54.84 – $92.34
52-week range$90.87
$54.11$92.59

What DexCom does

DexCom, Inc. is a medical technology company primarily focused on innovating, developing, and marketing continuous glucose monitoring (CGM) systems. Operating across the United States and internationally, the firm provides its solutions for individuals managing diabetes as well as for healthcare practitioners. Its product portfolio features the DexCom G6, a comprehensive CGM system for diabetes management; the Dexcom Real-Time API, enabling authorized third-party developers to integrate live CGM data into their digital health applications; the Dexcom ONE, which aims to supersede traditional finger-prick blood glucose testing for treatment decisions; and Dexcom Share, a remote monitoring platform. The company is also developing the Dexcom G7, its next-generation CGM system. Furthermore, DexCom, Inc. has a licensing and collaboration agreement with Verily Life Sciences LLC and Verily Ireland Limited to advance blood-based or interstitial glucose monitoring products. The company directly sells its offerings to specialists such as endocrinologists, physicians, and diabetes educators. DexCom, Inc. was founded in 1999 and maintains its headquarters in San Diego, California.

Key metrics

Market cap
$34.29B
P/E (TTM)
35.64
EPS (TTM)
$2.55
Beta
1.41
Dividend yield
0.00%
Revenue / share
$12.95
50-day avg
$80.02
200-day avg
$70.44
52-week high
$92.59
52-week low
$54.11
CEO
Jacob Steven Leach

ETFs linked to DXCM

Broad-market and Health Care sector ETFs an investor holding DexCom is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how DXCM fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze DXCM in PortView →

Similar companies

Frequently asked questions

What is the ticker symbol for DexCom?
DexCom trades under the ticker DXCM on NASDAQ.
Which exchange is DXCM listed on?
DXCM is listed on NASDAQ.
What sector does DexCom operate in?
DexCom is classified in the Health Care sector (Medical Devices industry).
How can PortView help analyze DXCM in a portfolio?
PortView shows DXCM's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.